Prudential Financial (PRU) at 7.6x Operating Earnings: Cheap for a Reason, or Just Cheap?

Assessment as of October 18, 2026, using the October 16 close of $115.91 (StockAnalysis). Multiples use Prudential's after-tax adjusted operating income (AOI) per share, the company's preferred measure of underlying earnings, unless labeled GAAP. Ratios and per-share estimates are the author's calculations.

The Short Answer

Prudential Financial is cheap because investors are worried, and the worry is reasonable. But the market is charging more for that worry than the numbers support. Over the last four reported quarters, Prudential earned $15.25 per share in adjusted operating income. At $115.91, that is a price-to-earnings (P/E) multiple of 7.6x, with a 4.8% dividend yield on top. In November 2024 the stock reached a weekly close of $129.11, in a year when it went on to earn $12.62 a share. Since then, earnings are up 21% and the price is down 10%.

My view: a measured Buy for patient, income-focused investors. I would buy in two tranches, the first now and the second after third-quarter results or the late-November deadline for Japan's improvement plans. It is not a Buy for anyone who needs a catalyst within six months. Wall Street's Hold consensus is right that no catalyst is near. I think it is wrong to treat today's price as fair value.

Key Takeaways

• Trailing AOI per share rose 15.9% year over year to $15.25 (Q3 2025 through Q2 2026, from company releases). The stock trades at 7.6x that figure and at 1.15x adjusted book value of $100.91.
• On October 9, Japan's Financial Services Agency (FSA) ordered Prudential of Japan to stop soliciting new business through January 31, 2027, and partially suspended Gibraltar Life's employed sales force (Prudential). The company puts the combined 2026–2027 cost at roughly $1.3 billion pre-tax, about $2.77 a share after tax, or 2.4% of the share price.
• None of the 18 analysts tracked by StockAnalysis rates the stock a Buy: 14 say Hold, 1 says Sell and 3 say Strong Sell. Their average target of $111.07 sits below today's price.
• From September 25 through October 16, PRU fell 3.0% while MetLife gained 3.1% (PRU history; MET history). That divergence points to company-specific concerns alongside sector risk.
• SPXScore's Opportunity Score for Prudential is 87.3, in the "supportive conditions" band. The valuation reading holds up. The earnings reading overstates the momentum, as explained below.

Six Years of Re-Pricing

Prudential's chart since 2020 is a series of round trips. Each low came with a story that the business was impaired, and each recovery came when earnings kept arriving anyway.

Period	Close	Price ÷ AOI per share	What the market was pricing
Mar. 2020	$46.77 (weekly)	n/a	Pandemic crash
Feb. 2022	$121.33 (weekly)	n/a	Recovery and rising rates
May 2023	$78.04 (weekly)	n/a	Banking stress, credit fears
Nov. 2024	$129.11 (weekly)	10.2x (2024: $12.62)	Higher rates as a tailwind
Apr. 2025	$95.12 (weekly)	7.5x (2024: $12.62)	Tariff sell-off
Mar. 2026	$94.49 (weekly)	6.5x (2025: $14.43)	Japan misconduct, sales halt
Aug. 14, 2026	$125.13	8.2x (TTM: $15.25)	Two earnings beats, strategy reset
Oct. 16, 2026	$115.91	7.6x (TTM: $15.25)	FSA orders, sector wobble

Prices: SPXScore weekly closes and StockAnalysis daily closes. EPS: Prudential's FY2025, Q3 2025, Q1 2026 and Q2 2026 releases. The November 2024 multiple uses full-year 2024 AOI, which was not reported until February 2025.

The latest round trip started in January, when Prudential of Japan disclosed that more than 100 current and former employees had defrauded customers (Insurance Business). On February 9 it began what was meant to be a 90-day voluntary halt to new sales (Barchart). By March the stock was at 6.5x earnings. Then results beat. First-quarter AOI of $3.61 a share topped the $3.24 consensus (Q1 release; WTOP/AP), and second-quarter AOI rose 14% to $4.08. Group Insurance posted record earnings and PGIM's operating income rose 28% (Q2 release; Quartr). By mid-August the stock had gained 32% from the March low.

Earnings Went Up. The Multiple Went Down. Why?

There are three reasons, and they are not equally convincing.

1. GAAP profits lag operating profits. Over the last four quarters, GAAP earnings per share were $11.17, only 73% of operating EPS. That gap keeps reappearing: an $0.85-per-share assumption-update charge in the second quarter and a $0.30 organizational charge in the fourth quarter of 2025 (Q2 release; FY2025 release). Skeptics are right to discount "one-time" items that recur. Even on GAAP numbers, though, the stock trades at 10.4x.

2. The sector is under suspicion. In April, Reuters reported that short bets against the 10 largest U.S. life insurers had grown by almost $3 billion in a year, to about $5.3 billion, as concern about private-credit exposure grew. Citing Moody's, the IMF estimates that roughly 35% of U.S. life insurers' balance sheets are tied to private lending (Reuters via MarketScreener). Barclays downgraded Prudential to Underweight that month (Placera). This is a real risk, but a broad one. On September 28, PRU fell 2.8% and MetLife fell 1.9% (StockAnalysis, PRU; StockAnalysis, MET).

3. Japan, a likely contributor to the recent gap. From August 14 through October 16, PRU fell 7.4% while MetLife gained 3.2%. Even measured from September 25, before that sector dip, PRU fell 3.0% while MetLife gained 3.1% (StockAnalysis, PRU; StockAnalysis, MET). Japan is a material difference between the two, though relative price moves alone cannot isolate its effect.

Japan: The Cost Is Quantified. The Damage Is Not.

The FSA's October 9 orders extended Prudential of Japan's ban on new solicitations to January 31, 2027. They also suspended Gibraltar Life's employed "Life Consultant" channel but not its independent agents, and they require improvement plans from all three Japanese entities by the end of November (Prudential). The FSA found that the company "failed to manage and supervise its sales employees adequately." It traced the fraud to 107 current and former employees who took roughly ¥3.1 billion from about 500 customers between 1991 and 2025 (Insurance Business).

On a conference call after the orders, as summarized by MarketBeat, management put the impact at about $1 billion of pre-tax AOI for Prudential of Japan across 2026 and 2027, plus about $275 million for Gibraltar. By year, that is roughly $600 million in 2026 and $675–725 million in 2027 (MarketBeat via TradingView). After tax at an assumed 25%, that is roughly $2.77 a share, or 2.4% of the share price. This puts the estimated two-year earnings reduction in perspective; it does not measure the full valuation damage. Weaker sales beyond 2027, customer losses and a higher required return could justify a larger discount.

Prudential's October 15 filing supplies an early Q3 data point: an estimated $140 million pre-tax AOI reduction from the Prudential of Japan suspension. This is preliminary and unaudited, and covers that unit's third-quarter impact rather than the combined two-year estimate. The filing also separates certain emerging-market businesses from the former International Businesses segment and renames it Japan Businesses, with historical segment figures revised retrospectively.

The reopening plan matters more. Prudential of Japan expects 2027 sales of only about 25% of 2025 levels, down from its previous assumption of 50%, rising to 50% in 2028 and full productivity by 2029. Even that depends on keeping its Life Planner sales force intact (TradingView). Under the original Q2 segment presentation, International Businesses produced 41% of segment operating income before corporate costs ($855 million of $2.1 billion, per the Q2 release). That included businesses outside Japan and is not a Japan-only share under the revised presentation.

The business is losing new sales, but in-force policies provide support: more than 90% of Gibraltar's operating income comes from its existing book (TradingView). Surrenders also moderated in the second quarter, below the company's expectations (Q2 call). In the first quarter, Prudential of Japan's Life Planner headcount fell less than 1%, and resignation rates were flat year over year (Q1 call). The larger estimated Japan impact in 2027 helps explain the limited growth in StockAnalysis's October 16 consensus: adjusted EPS of $14.24 in 2026 and $14.44 in 2027.

What SPXScore's Model Gets Right, and What It Overstates

SPXScore's Opportunity Score combines earnings yield, earnings change, price trend and price stability. For PRU, the four pillars read 0.98, 1.00, 0.66 and 0.90 (computed from SPXScore's weekly data).

The value pillar holds up. A 9.6% GAAP earnings yield, or 13.2% on operating earnings, is high for a large insurer that is paying out only 37% of operating EPS as dividends. The earnings pillar does not. It reads a perfect 1.00 because GAAP trailing EPS jumped 144% (from $4.58 to $11.17 in SPXScore's data), but most of that jump comes from comparison with weak quarters in 2024, including a GAAP loss in the fourth quarter. Operating EPS grew a healthy but ordinary 15.9%. The score moved from about 25 a year ago to above 70 in February. That move was largely mechanical: the weak 2024 quarters dropped out of the trailing window. The business did not change that suddenly. So the thesis survives scrutiny on valuation, not on momentum.

The Street Says Hold. Is It Justified?

Analysts have recently cut targets: KBW to $119, JPMorgan to $127, Wells Fargo to $104 (Sell) and Mizuho to $108 (StockAnalysis). MarketBeat's tally is harsher, a "Reduce" consensus with a $107.85 average target (MarketBeat).

The $111.07 average target implies 7.7x 2027 consensus EPS. In effect, analysts are saying the discount should persist until Japan reopens and the August strategy reset delivers. That reset is ambitious. It includes $750 million of pre-tax run-rate savings by 2028 and exits from about half of Prudential's international markets, which management expects to free up "well north of $3 billion" in capital (Q2 call). Analysts on the call pushed back. JPMorgan's analyst questioned "selling low multiple businesses to potentially acquire more expensive businesses," and Bank of America's said such plans are "hard to execute but easy to cut."

I agree with the Street's caution on timing, but not on value. Among the five S&P 500 life insurers in SPXScore's peer data, Prudential is the cheapest on forward earnings. At $115.91, it trades at 1.28x June 30 GAAP book value of $90.50 per share, or 1.15x adjusted book value of $100.91, using the company's Q2 release. These are distinct accounting bases, not conflicting multiples.

Prudential raised its dividend for an 18th straight year in February. The annualized $5.60 payment yields 4.8% at today's price. Its $1 billion 2026 buyback authorization, equivalent to about 2.5% of current market value, provides a separate route for returning capital (FY2025 release). Authorization does not guarantee execution, and repurchases are not cash dividends to continuing holders. The income case rests on the dividend; completed buybacks can support per-share value.

Rates Cut Both Ways

The Fed raised rates to 3.75%–4.00% on September 16 (Federal Reserve), and the 10-year Treasury yield was 5.10% on October 15 (FRED). Higher yields gradually raise what a life insurer earns when it reinvests premiums and maturing bonds. Spikes like the one we covered in our Treasury yields analysis also hurt. They lower GAAP book value, can encourage annuity policyholders to surrender policies for better yields elsewhere, and add pressure to private-credit borrowers. Another hike at the late-October Fed meeting would be a mixed signal for PRU, not a clear negative.

Scenarios and Verdict

The horizon is the end of 2027, when investors will be pricing 2028 earnings and Japan's reopening will have a track record. The probabilities are my own judgment.

Scenario	Probability	Assumption	Price, end-2027	Price return	With dividends
Bear	25%	Reopening stalls; 6.5x, the March-low multiple, on 2027 consensus EPS of $14.44	~$94	−19%	−13%
Base	50%	No re-rating; today's ~8x forward multiple on a 2028 estimate of $16.15	~$129	+11%	+18%
Bull	25%	Re-rates to MetLife's 9.0x on $16.15	~$145	+25%	+31%
Weighted			~$124	+7%	+13%

Both the base and bull cases use Dowling & Partners' $16.15 estimate for 2028, via MarketBeat. This is a single firm's forecast, not a consensus estimate. The bear case uses StockAnalysis's 2027 consensus of $14.44. Dividends assume five more quarterly payments of $1.40 with no increase. The bear multiple was a trailing figure; it is applied to forward EPS for simplicity.

On these assumptions, the expected return is about 13% over roughly 14 months, against a downside of about 13% in the bear case. The base case does not need the market to like Prudential more, only for it to keep paying the same multiple as earnings recover from Japan. That is attractive but not lopsided, which is why I would buy in stages. As with our call on Assurant, I would hold back part of the position.

Third-quarter results are scheduled for November 3 after market close, followed by a November 4 call (Prudential announcement). They will expand on the October 15 preliminary update and provide an opportunity to assess management's two-year Japan estimate. Improvement plans are due to the FSA by November 30; submission alone will not establish regulatory approval.

Three developments would change my view: another extension of the Japan suspension beyond January 31, evidence that Life Planners are leaving faster than they did in the first quarter, or sales of emerging-market businesses at prices below book value. Until then, PRU looks like a stock whose problems are already reflected in the price.

---

This article discusses Prudential Financial's historical stock performance and the business, regulatory and macroeconomic conditions surrounding it as of October 18, 2026, for informational purposes only. It is not investment advice or a recommendation to buy, hold, or sell any security. Prudential's full third-quarter 2026 results had not been reported at the time of writing; selected preliminary figures were disclosed on October 15. Japan impact estimates, analyst targets and consensus EPS figures are subject to revision.